HemCon acquires Alltracel
This article was originally published in The Tan Sheet
Executive Summary
HemCon Medical Technologies completes its cash-for-stock takeover of Alltracel Pharmaceuticals, a Dublin, Ireland-based licensing and distribution firm specializing in cosmeceuticals, nutraceuticals and wound care markets, according to a May 14 release. The deal expands distribution opportunities for HemCon's chitosan-based bandage products used by military and medical first responders, the Portland, Ore.-based wound care firm says. The acquisition also gives HemCon access to Alltracel's nanotechnology-development joint venture with Elmarco and its proprietary Nanospider manufacturing process, which HemCon will leverage "to develop and aggressively grow its market share in acute wound care products," the firm says...